April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
April 12, 2012 – Abbott announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next ...
April 16, 2012 - 480 Biomedical announced that it has initiated the first human trial of its groundbreaking Stanza self ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
April 12, 2012 — The Maryland General Assembly set a high bar for the nation and showed its commitment to patients by ...
April 6, 2012 — Boston Scientific Corp. announced results from a quantitative coronary angiographic (QCA) analysis of ...
April 5, 2012 — Arterial Remodeling Technologies (ART) reported yesterday that in vivo data strongly suggest that its ...
April 2, 2012 — Boston Scientific announced its support of the HORIZONS II AMI clinical trial, which is designed to ...
March 29, 2012 – Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and ...
March 29, 2012 — In the second year of an ongoing trial, the Resolute zotarolimus-eluting stent (Medtronic) achieved a ...
March 27, 2012 — Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than ...
March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege ...
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...
March 16, 2012 — The U.S. Food and Drug Administration (FDA) approved the premarket approval (PMA) application for the ...
March 16, 2012 - Depression increases the risk of death in patients who have a coronary stent implanted. After seven ...
March 9, 2012 — Boston Scientific Corp. announced the launch of the Promus Element everolimus-eluting coronary stent sys ...